N-acetyl-L-cysteine Zinc Chelate for Enhanced Mineral Bioavailability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current nutritional supplements fail to effectively address oxidative stress, neurodegenerative diseases, and mineral deficiencies due to poor absorption and bioavailability of essential minerals like iron, zinc, and magnesium, and lack of antioxidant properties that can cross the blood-brain barrier.
Innovation Solution
A chelate formulation of N-acetyl-L-cysteine (NAC) bonded with metals such as iron, zinc, and magnesium, which enhances mineral absorption and bioavailability while providing antioxidant properties by forming stable rings that can cross the blood-brain barrier, thereby treating oxidative stress and neurodegenerative diseases.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional mineral supplements are used, then mineral content is provided, but absorption and bioavailability are poor
Solution Approach 1:
The patent applies composite materials by combining N-acetyl-L-cysteine with metal ions (Fe2+, Fe3+, Zn2+, Mg2+, Ca2+) to form chelate complexes. This composite structure improves mineral absorption and bioavailability while maintaining stability, directly resolving the contradiction between reliable mineral delivery and ease of formulation.
Solution Approach 2:
The patent changes the chemical state of minerals from simple salts to chelated complexes with specific molar ratios (1:1, 2:1, 3:1, 4:1 of NAC to metal). This parameter change in molecular structure and bonding configuration enhances absorption properties while providing a systematic manufacturing approach.
2Reliability
If NAC-metal chelate formulation is used, then mineral absorption is improved, but formulation complexity increases
Solution Approach 1:
The patent segments the formulation process into distinct stages: dissolving NAC in aqueous solution, adding metal salts, heating at specific temperatures (60-100°C) for controlled periods (1-24 hours), and evaporating to obtain chelates. This segmentation makes the complex chelation process manageable and reproducible.
Solution Approach 2:
The patent creates a universal chelate formulation method that can accommodate multiple metal ions (Fe, Zn, Mg, Ca) using the same NAC ligand and general procedure. This multi-functionality reduces formulation complexity by providing a single versatile platform for different mineral supplements.
3Reliability
If NAC chelates are used, then antioxidant properties and blood-brain barrier crossing are achieved, but manufacturing process becomes more complex
Solution Approach 1:
The patent employs self-service by allowing NAC and metal ions to spontaneously form chelate complexes under mild heating conditions without requiring complex catalysts or specialized equipment. The chelation occurs naturally through the thiol group of NAC binding to metal ions, simplifying manufacturing while ensuring antioxidant efficacy.
Solution Approach 2:
The patent optimizes manufacturing parameters including temperature (60-100°C), time (1-24 hours), pH control, and molar ratios to facilitate spontaneous chelation. These parameter adjustments enable effective antioxidant chelate formation through a relatively simple heating and evaporation process.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The NAC-metal chelate formulation improves mineral absorption, increases glutathione levels, and effectively treats oxidative stress, neurodegenerative diseases, and mineral deficiencies, offering enhanced bioavailability and antioxidant benefits.
Implementation Method 1
a chelate made of an N-acetyl-L-cysteine ligand bonded to a metal to form a chelate ring
Implementation Method 2
stirring and heating the aqueous solution
Implementation Method 3
removing the solvent under reduced pressure
Data Source
AI summary
A nutritional supplement for a human, the supplement having a chelate comprised of an N-acetyl-L-cysteine ligand bonded to zinc to form a chelate ring. A method of treating a human for one or more of oxidative stress, cardiovascular disease, cerebrovascular disease, neurodegenerative diseases, Alzheimer's disease, ADHD, bipolar, schizophrenia, autism, dementia, and HIV in a human comprising administering an effective amount of a composition having N-acetyl-L-cysteine in a chelate formation with zinc. A compound having a chelate formulation with zinc being chelated by an N-acetyl-L-cysteine ligand.